ABSTRACT
STUDY OBJECTIVE: To compare the outcome of robotic-assisted laparoscopy vs conventional laparoscopy in the management of ovarian masses. DESIGN: Retrospective cohort (Canadian Task Force classification II-3). SETTING: Academic medical centre in the northeast United States. PATIENTS: Retrospective medical record review of 71 consecutive patients with presumed benign ovarian masses. INTERVENTION: Robotic-assisted laparoscopy in 30 patients with presumed benign ovarian masses was compared with conventional laparoscopy in 41 patients. MEASUREMENTS AND MAIN RESULTS: Operative outcomes including operative time, estimated blood loss, length of hospital stay, and complications were recorded. Standard statistical analysis was used to compare the outcomes in the 2 groups. Mean (SD) operative time in the robotic group was 1.95 (0.63) hours, which was significantly longer than in the conventional laparoscopic group, 1.28 (0.83) hours (p = .04). Estimated blood loss in the robotic group was 74.52 (56.23) mL, which was not significantly different from that in the conventional laparoscopic group, 55.97 (49.18) mL. There were no significant differences in length of hospital stay between the robotic and conventional laparoscopic groups: 1.20 (0.78) days and 1.48 (0.63). Conversion to laparotomy was not necessary in either group of patients. Intraoperative and postoperative complications were similar between the 2 groups. CONCLUSION: Robotic-assisted laparoscopy is a safe and efficient technique for management of various types of ovarian masses. However, conventional laparoscopy is preferred for management of ovarian masses because of shorter operative time. Prospective studies are needed to evaluate the outcomes of robotic-assisted laparoscopic management of benign and malignant ovarian neoplasms.
Subject(s)
Adnexal Diseases/surgery , Laparoscopy , Ovarian Cysts/surgery , Robotic Surgical Procedures , Adnexal Diseases/epidemiology , Adult , Aged , Female , Humans , Laparoscopy/adverse effects , Laparoscopy/instrumentation , Laparoscopy/methods , Length of Stay , Middle Aged , Ovarian Cysts/epidemiology , Ovarian Neoplasms/epidemiology , Ovarian Neoplasms/surgery , Postoperative Complications/epidemiology , Postoperative Complications/etiology , Retrospective Studies , Robotic Surgical Procedures/adverse effects , Robotic Surgical Procedures/methods , Treatment OutcomeABSTRACT
The purification and refolding of the recombinant horseradish peroxidase produce by E. coli transformants are described. The recombinant enzyme is of 34 kDa and has an isozyme spectrum similar to Sigma type VI horseradish peroxidase. The specific activity of the refolded peroxidase is of about 2000 U/mg with ABTS as a substrate. The recombinant and native enzyme are similar with respect to their catalytic properties in the reaction of enhanced chemiluminescence. Operational and thermal stability of the refolded peroxidase is two to three times lower than for the native one.
Subject(s)
Horseradish Peroxidase/metabolism , Isoenzymes/metabolism , Enzyme Stability , Escherichia coli/genetics , Horseradish Peroxidase/chemistry , Horseradish Peroxidase/genetics , Hydrogen-Ion Concentration , Isoenzymes/chemistry , Isoenzymes/genetics , Kinetics , Luminescent Measurements , Molecular Weight , Protein Folding , Recombinant Proteins/chemistry , Recombinant Proteins/genetics , Recombinant Proteins/metabolism , Transformation, GeneticABSTRACT
The binding of the opioid antagonist [3H]-naloxone to immunocompetent cells of the mouse, F1(CBA x C57B1/6), in medium 199 has been studied. The binding was reversible and reached a maximum during 15-20 min at 37 degrees C. The stereospecificity profile was proven to correspond to mu-type receptors. The binding curve was characterized by high positive cooperativity (nH = 2.3, IC50 = 5 nM). Mitogenic stimulation by Con A, SEA, and ML caused an increase in the number of receptors. Besides, stimulation by an antigen (ovalbumin) changed the binding parameters. The distribution of binding sites for naloxone on various immunocompetent cells was investigated. The maximal number of sites was found on lymphocytes of lymph nodes and bone marrow cells. A conclusion is drawn that both T- and non-T-cells play a role in naloxone binding.
Subject(s)
Antigens/immunology , B-Lymphocytes/metabolism , Mitogens , Naloxone/metabolism , T-Lymphocytes/metabolism , Animals , B-Lymphocytes/immunology , Female , Lymphoid Tissue/cytology , Male , Mice , Mice, Inbred C57BL , Mice, Inbred CBA , Receptors, Opioid/metabolism , Substrate Specificity , T-Lymphocytes/immunology , TritiumABSTRACT
The kinetics of peroxidase-dependent cooxidation for two substrate pairs [p-iodophenol + 4-aminoantipyrine (AAP) and p-iodophenol + luminol was studied both in the absence and presence of polyclonal antibodies (polyAB), three types of peroxidase-specific monoclonal antibodies (monoAB) and their double or triple mixtures in a wide range of H2O2 concentrations (0.01-10.0 mM). MonoAB 2C, 3E and 9D at concentrations of 0.05-500 nM inhibited the cooxidation of p-iodophenol + AAP at H2O2 concentration above 1.0 mM but activated the cooxidation of p-iodophenol + luminol. The double and triple mixtures of monoAB activated the cooxidation of p-iodophenol + AAP at the same H2O2 concentrations without any effect on the p-iodophenol + luminol cooxidation. PolyAB activated the cooxidation of p-iodophenol + AAP more effectively and only slightly activated (or inhibited) that of p-iodophenol + luminol. PolyAB diminished the values of rate constants for the interaction of the peroxidase active intermediates, E1 and E2, with p-iodophenol, AAP or luminol. Possible modes of monoAB and polyAB effects on the two substrate pair cooxidation are discussed.
Subject(s)
Ampyrone/chemistry , Antibodies, Monoclonal , Iodobenzenes/chemistry , Luminol/chemistry , Peroxidases/immunology , Kinetics , Molecular Sequence Data , Oxidation-ReductionABSTRACT
The influence of Met-enkephalin on mitogenic stimulation of mouse splenocytes was investigated. Met-enkephalin (ME) was shown to suppress proliferation induced by Concanavalin A and activate proliferation induced by Staphylococcus enterotoxin A. Both effects were revealed at low (down to 10(-14) M) concentration of pentapeptide. Naloxone reversed ME influence on cell activation. The number of receptors for naloxone was shown to increase up to 2.5-fold during mitogenic activation. The difference in expression of various types of opioid receptors at mitogenic stimulation was demonstrated by ligand displacement experiments.
Subject(s)
Enkephalin, Methionine/pharmacology , Lymphocyte Activation/drug effects , Receptors, Opioid/physiology , Animals , Binding, Competitive , Concanavalin A/pharmacology , Diprenorphine/metabolism , Diprenorphine/pharmacology , Enterotoxins/pharmacology , Female , Mice , Mice, Inbred C57BL/immunology , Mice, Inbred CBA/immunology , Naloxone/pharmacology , Pain/physiopathology , Receptors, Opioid/drug effects , Receptors, Opioid, delta , Receptors, Opioid, mu , Sensory Thresholds , Spleen/cytologySubject(s)
Escherichia coli/genetics , Horseradish Peroxidase/genetics , Isoenzymes/genetics , Catalysis , Chromatography, High Pressure Liquid , Horseradish Peroxidase/chemistry , Horseradish Peroxidase/metabolism , Isoelectric Focusing , Isoenzymes/chemistry , Isoenzymes/metabolism , Plasmids , Recombinant Proteins/chemistry , Recombinant Proteins/genetics , Recombinant Proteins/metabolism , Restriction MappingABSTRACT
The properties of a peroxidase from Arthromyces ramosus (ARP) in the chemiluminescent reaction of luminol oxidation have been studied. These were compared with the properties of horse radish peroxidase (HRP) in the cooxidation of luminol and p-iodophenol, the enhanced chemiluminescence (ECL) reaction. By means of the stop-flow technique, ARP was shown to have an enzymatic activity toward luminol higher than that toward HRP. ARP can efficiently catalyze luminol oxidation in the absence of substrate enhancer. pH and substrate concentrations were optimized to determine ARP with the highest sensitivity. The detection limit of ARP was 5 x 10(-13) M, the same as that for HRP in the ECL reaction. The data on the use of ARP as a label in enzyme immunoassay of human IgG are presented. ARP was shown to have all the advantages of HRP as a label in chemiluminescent enzyme immunoassays: (i) high signal intensity, (ii) slow decay of luminescence, (iii) high signal/noise ratio, and (iv) as a consequence of (i)-(iii), high detection sensitivity. However, the low thermostability of ARP can limit the potential fields of its application.
Subject(s)
Fungi/enzymology , Horseradish Peroxidase/metabolism , Luminol , Peroxidases/metabolism , Enzyme Stability , Indicators and Reagents , Kinetics , Luminescent Measurements , MathematicsABSTRACT
Properties of four types of monoclonal antibodies to horse-radish peroxidase were investigated. The dissociation constants and molecular-weight composition of the immune complexes were determined. The antibodies are shown to be directed to different epitopes on the polypeptide chain. Results of the theoretical prediction of the epitope localisation are presented. The interaction between the antibodies and peroxidase isozymes were studied.
Subject(s)
Antibodies, Monoclonal/immunology , Horseradish Peroxidase/immunology , Amino Acid Sequence , Blotting, Western , Chromatography, Gel , Electrophoresis, Polyacrylamide Gel , Hydrolysis , Immunoglobulin G/immunology , Molecular Sequence Data , Sequence Homology, Nucleic AcidABSTRACT
Some biochemical and catalytic properties of peroxidase from Arthromyces ramosus (EC 1.11.7.1) in chemiluminescent reaction of luminol oxidation by hydrogen peroxide were investigated. The second order rate constants were determined by the stopped-flow technique. Optimal conditions to quantity the enzyme were found, the detection limit being 5.10(-13) M. The peroxidase was used as a marker in the human IgG immunoassay.
Subject(s)
Coprinus/enzymology , Peroxidases/immunology , Catalysis , Hydrogen Peroxide/chemistry , Immunoenzyme Techniques , Immunoglobulin G/analysis , Isoelectric Focusing , Kinetics , Luminol/chemistry , Oxidation-Reduction , Peroxidases/chemistryABSTRACT
In this communication some of the advantages and constraints in the use of ELISA (enzyme-linked immunosorbent assay) procedures to evaluate antigen-antibody dissociation constants (Kd) are discussed and experimental conditions under which the effective Kd is close to the true value are proposed. Interactions between horseradish peroxidase (POD), human myoglobin and insulin with mono- and polyclonal antibodies (McAb and PcAb) were used to demonstrate that ELISA can be used to determine the average Kd, characterizing the interaction between antigens and PcAb. The Kd values obtained by ELISA were similar to those determined by luminescent immuno-cofactor analysis (LICA).
Subject(s)
Antigen-Antibody Complex/metabolism , Animals , Antibodies, Monoclonal , Enzyme-Linked Immunosorbent Assay , Guinea Pigs , Horseradish Peroxidase/immunology , Insulin/immunology , Mice , RabbitsABSTRACT
The mechanism of peroxidase-catalysed oxidation of luminol by H2O2 was studied. The stopped-flow technique was used to measure the rate constants for the reactions between the oxidized forms of peroxidase with luminol and the following substrates: p-iodophenol, p-bromophenol, p-clorophenol, o-iodophenol, m-iodophenol, luciferin, and 2-iodo-6-hydroxybenzothiazole. The correlation between kinetic parameters and the degree of enhancement was established. The effect of charged synthetic polymers and specific antibodies on the peroxidase activity in the enhanced chemiluminescent reaction was also studied. The close approach of an effector molecule to the active site of the enzyme was found to inhibit the enhanced chemiluminescent reaction. Novel homogeneous methods of luminescent immunoassay (LIA) for (1) antibodies to insulin, (2) insulin and (3) antibodies to trinitrophenyl group are proposed on the basis of regulatory facilities of the enhanced chemiluminescent reaction. Based on the enhanced chemiluminescent reaction a peroxidase flow-injection assay was developed and successfully tested in the flow-injection enzyme immunoassays for human IgG and for thyroxin (T4). The immunoassay proposed has a detection limit of 10(-9) M for IgG and 10(-11) M for T4, the overall time of the assay being 5-15 min.
Subject(s)
Immunochemistry , Immunoenzyme Techniques , Luminescent Measurements , Haptens , Horseradish Peroxidase , Humans , Immunoglobulin G/analysis , Insulin/analysis , Insulin Antibodies/analysis , Kinetics , Luminol , Oxidation-Reduction , Substrate Specificity , Thyroxine/analysisABSTRACT
Monoclonal antibodies to horseradish peroxidase were obtained. The interaction of two antibody clones with the enzyme was studied. Antibodies of one clone were found to inhibit the enzyme activity during the oxidation of 2.2'-azinobis-(3-ethylbenzothiazoline-6-sulfonate) diammonium salt and the cooxidation of luminol and luciferin. The latter was concomitant with a complete inhibition of the peroxidase activity. The values of binding constants as determined by the solid phase immunoenzymatic and homogeneous methods are equal to (1.2 +/- 0.5).10(8) M-1 and (1.8 +/- 0.2).10(11) M-1, respectively.